Metraipolis › archive › dc_7e447701f81f

Association of SGLT2 Inhibitor Use with All-Cause Mortality Following CIED Implantation for Conduction Disease in Patients with Preserved LVEF: A… — Europe PMC PMID:42513594

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42513594
DOI
10.3390/jcm15145681
License (as archived)
solo-consultazione
Archived
2026-10-18T03:27:57.240Z
SHA-256 of the archived text
ba91a09622ba9f2564d1f689edbb6ec5f4875fdfd480c3f840ffcf6c7c3a93fe
Stable URL of this page
https://metraipolis.com/documento/dc_7e447701f81f

How to cite

Association of SGLT2 Inhibitor Use with All-Cause Mortality Following CIED Implantation for Conduction Disease in Patients with Preserved LVEF: A… — Europe PMC PMID:42513594 — Europe PMC (en), https://europepmc.org/article/MED/42513594 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e447701f81f (Metraipolis archive dc_7e447701f81f, sha256 ba91a09622ba9f2564d1f689edbb6ec5f4875fdfd480c3f840ffcf6c7c3a93fe)
BibTeX
@misc{dc7e447701f81f,
  title = {Association of SGLT2 Inhibitor Use with All-Cause Mortality Following CIED Implantation for Conduction Disease in Patients with Preserved LVEF: A… — Europe PMC PMID:42513594},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42513594},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e447701f81f; sha256 ba91a09622ba9f2564d1f689edbb6ec5f4875fdfd480c3f840ffcf6c7c3a93fe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42513594. Agents can read the archived copy with the MCP tool read_document.